Table 1 Inclusion and non-inclusion criteria

✓ Adult patients (aged > 18 years), woman without childbearing potential or active contraception (intrauterine device, contraceptive pill, or contraceptive implant)

✓ Patient with other retinal pathologies such as age-related macular degeneration (“AMD”), retinal vein occlusion, diabetic retinopathy, glaucoma with macular visual field defect

✓ Patients with an idiopathic symptomatic epimacular membrane; for patients with both eyes affected, the treated eye in the protocol will be the one that is most severely affected

✓ Patients with uveitis or a history of uveitis

✓ Pseudophakic patients with transparent posterior capsule or open capsule or lensed patients with age-related cataracts

✓ Patients with any recent eye injuries or eye surgeries (< 6 months)

✓ Patients with social security

✓ Patients participating in interventional clinical trial

✓ Patients able to understand and follow the trial instructions

✓ Pregnant or breastfeeding women

✓ Patients who have signed an informed consent

✓ Vulnerable people: persons deprived of liberty, under trusteeship, or under curatorship